X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Rachel Licata

Rachel Licata Rachel is a senior director of policy and research at PhRMA focusing on the Affordable Care Act and other public programs. Prior to joining PhRMA she worked at the Kaiser Family Foundation and the Department of Health and Human Services. Rachel enjoys taking yoga classes and exploring the local cuisine of the Maryland suburbs.

Recent Posts

340B Spotlight: Trends in shifting site of care

By Rachel Licata  |    September 21, 2016
Research has shown once health care services shift from a provider’s office to a hospital, treatment costs for payers and patients increase. One way hospitals drive this site of care shift is...   Read More

Local Impact: State-by-state Medicaid spending on prescription medicines

By Rachel Licata  |    December 16, 2015
We’ve talked before about how prescription medicines comprise a small share of Medicaid spending. In recent years new life-changing, innovative medicines have come to market to help patients live...   Read More

340B Spotlight: ICYMI – New study on hospital-physician practice consolidation

By Rachel Licata  |    November 3, 2015
In case you missed it, a recent study in JAMA Internal Medicine, “Association of Financial Integration Between Physicians and Hospitals with Commercial Health Care Prices,” looked at the spending...   Read More

ICYMI: Higher out-of-pocket costs in health insurance exchange plans compared to employer plans for patients managing chronic conditions

By Rachel Licata  |    October 7, 2015
A recent study published in Health Affairs took a look at estimated out-of-pocket expenses for individuals living with chronic conditions if they switched from average employer-sponsored plans to...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates